Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors

Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors

Muscle invasive bladder cancer (MIBC) is a widespread malignancy with a worse prognosis often related to a late diagnosis. For early-stage MIBC pts, a multidisciplinary approach is mandatory to evaluate the timing of neoadjuvant chemotherapy (NAC) and surgery. The current standard therapy is platinu...

Full description

Bibliographic Details
Main Authors: Maria Lucia Iacovino, Chiara Carmen Miceli, Marco De Felice, Biagio Barone, Luca Pompella, Francesco Chiancone, Erika Di Zazzo, Giuseppe Tirino, Carminia Maria Della Corte, Ciro Imbimbo, Ferdinando De Vita, Felice Crocetto
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:International Journal of Molecular Sciences
Subjects:
bladder cancer
urothelial cancers
neoadjuvant chemotherapy
Immune Checkpoint Inhibitors
molecular classification of muscle-invasive bladder cancer
muscle-invasive bladder cancer
Online Access:https://www.mdpi.com/1422-0067/23/3/1133

Internet

https://www.mdpi.com/1422-0067/23/3/1133

Similar Items